bioAffinity Technologies, Inc. Share Price

bioAffinity Technologies, Inc. Share Price

NASDAQ: BIAF | Micro Cap
$3.06
+$0.14 (4.62%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

bioAffinity Technologies, Inc. Stock Performance

Open
$3.15
Prev. Close
$2.92
Circuit Range
N/A
Day Range
$3.15 - $3.15
Year Range
$0.39 - $20.22
Volume
628
Average Traded
$3.15

bioAffinity Technologies, Inc. Share Price Today

As of 30 October 2026, bioAffinity Technologies, Inc.'s share price is $3.06. The stock opened at $3.15, compared to its previous close of $2.92. During today's trading session, bioAffinity Technologies, Inc.'s share price traded between $3.15 and $3.15, with an average price of $3.15. Over the past 52 weeks, the stock has recorded a high of $20.22 and a low of $0.39. In terms of performance, bioAffinity Technologies, Inc.'s share price has risen by 22.20% over the last six months and is up 24.69% on a year-on-year basis.

bioAffinity Technologies, Inc. Share Price Chart

Line chart of the bioAffinity Technologies, Inc. price trend over the selected period. The price rose overall, ranging from 3.06 to 3.21, ending at 3.06.
$3.15$3.15
L
Show Current Price
H

bioAffinity Technologies, Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-25.28
Revenue (TTM)
$6.16B
Return On Equity (TTM)
-402.92%
Profit Margin
-242.05%
Debt to Equity
0.17
Quarterly Earnings Growth YoY
33.27%

bioAffinity Technologies, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.45$1.59$1.35$1.51
Net Profit-$5.05-$3.14-$3.63-$3.37
Net Profit Margin-348.28%-197.48%-268.89%-223.18%
Income ChangeN/A37.82%-15.61%7.16%

bioAffinity Technologies, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$2.53$9.36$6.16
Net Profit-$8.15-$7.94-$9.04-$14.91
Net Profit MarginN/A-313.83%-96.58%-242.05%
Income ChangeN/A2.58%-13.85%-64.93%

About bioAffinity Technologies, Inc.

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

bioAffinity Technologies, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$6.66
$3.15
-53.51%
Sep 2026
$7.51
$6.78
+32.32%
Aug 2026
$0.59
$5.12
+716.59%
Jul 2026
$0.85
$0.63
-23.35%
Jun 2026
$1.74
$0.82
-51.02%
May 2026
$2.41
$1.67
-33.20%
Apr 2026
$4.32
$2.50
-35.23%
Mar 2026
$1.01
$3.86
+274.76%
Feb 2026
$1.18
$1.03
-10.43%
Jan 2026
$1.25
$1.15
-7.26%
Dec 2025
$1.54
$1.24
-15.93%
Nov 2025
$2.33
$1.48
-39.80%

BIAF Share Price FAQs